Brief: Atai Life Sciences NV reports Q2 results
15/08/2022 12:43
Aug 15 (Reuters) - ATAI Life Sciences NV 9VC.F :
* ATAI LIFE SCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
& BUSINESS UPDATE
* ATAI LIFE SCIENCES NV - ADDED AN ANTICIPATED ADDITIONAL
YEAR OF
RUNWAY INTO 2025 THROUGH SECURING NON-DILUTIVE DEBT FACILITY
FROM HERCULES
* ATAI LIFE SCIENCES NV- QTRLY LOSS PER SHARE $0.24
Source text for Eikon: ID:nGNX8Cz6DR
Further company coverage: 9VC.F
Recent news on Hercules Capital
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Broadening credit concerns driving BDC weakness, KBW says
Brief: Hercules Capital Prices Upsized Institutional Notes Offering Of $400.0 Million 6.70% Notes Due 2029
Hercules Capital Q2 investment income rises to record high
Brief: Hercules Capital Closes Institutional Notes Offering Of $325.0 Million 6.300% Unsecured Notes Due 2031